Laurel Messer on Muck Rack

Laurel Messer

Denver
As seen in: JAMA (The Journal of the American Medical Association), Mary Ann Liebert, Inc., Healio, Diabetes Care Magazine, Diabetes Spectrum Magazine, American Journal of Managed Care, diaTribe, Diabetes Research and Clinical Practice, Journal of Pediatric Nursing
Diabetes technology obsessed. Lover of butter
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Laurel

Contact Laurel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Situational Awareness and Proactive Engagement Predict Higher Time in Range in Adolescents and Young Adults Using Hybrid Closed-Loop

|
By Laurel Messer, Paul Cook, Sriram Sankaranarayanan
Background. Adolescents and young adults with type 1 diabetes have high HbA1c levels and often struggle with self-management behaviors and attention to diabetes care. Hybrid closed-loop systems (HCL) like the t:slim X2 with Control-IQ technology (Control-IQ) can help improve glycemic control. The purpose of this study is to assess adolescents’ situational awareness of their glucose control and engagement with the Control-IQ system to determine significant factors in daily glycemic control. Methods.
Open in Who Shared Issue with article?

Bionic pancreas reduces HbA1c, improves time in range in type 1 diabetes: Pivotal data

|
By Katie Kalvaitis Verified, Laurel Messer
| Endocrine Today Verified
Source/Disclosures Source: Forlenza G, et al. The Insulin-Only Bionic Pancreas Pivotal Trial – Randomized Clinical Trial Results. Presented at: American Diabetes Association Scientific Sessions; June 3-7, 2022; New Orleans (hybrid meeting). Disclosures: Forlenza reports receiving research support from Abbott, Dexcom, Insulet, Lilly and Medtronic and consulting, speaking and/or serving on advisory boards for Abbott, Beta Bionics, Dexcom, Insulet, Lilly, Medtronic and Tandem.
Open in Who Shared Issue with article?
|
By Laurel Messer, Paul Cook, Nancy K. Lowe, Korey K Hood, Paul Cook, Kimberly A. Driscoll, Teri L. Hernandez
| Journal of Pediatric Nursing Verified
Highlights • Predictors of consistent Continuous Glucose Monitor (CGM) use in adolescents with diabetes are unknown, but important • In this study, adolescents who were younger, non-Hispanic White, privately insured were more likely to wear CGM consistently. • Adolescents who perceived high benefit to CGM use and lower burden were more likely to wear CGM consistently (≥ 6 days/week). • Future nurse-led interventions should include promoting benefits and reducing burden with CGM use.
Open in Who Shared Issue with article?
See all 15 licensed articles (18 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified